In his first public appearance as…
In his first public appearance as Incyte’s CEO, Bill Meury [...]
In his first public appearance as Incyte’s CEO, Bill Meury [...]
Regeneron is having difficulties again with its manufacturing partner Novo [...]
As Moderna plows ahead with its multiyear cost-savings scheme, the [...]
Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine [...]
In honor of the annual World Lung Cancer Day commemoration [...]
A stellar launch of Amvuttra in the rare heart disease [...]
Merz Aesthetics has revamped its sales and marketing leadership, promoting [...]
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic [...]
The latest move by President Donald Trump to try to [...]
Merck will reduce its workforce by approximately 6,000 employees in [...]